Quick Overview: Paul Nghiem talks about the future of MCC treatment and how far we have come in 10+ years. He emphasizes how patients are ... Dr. Peter A. Merkel of UPenn on VCRC and Relapsing Polychondritis (RP) Recording of the June 13, 2025, virtual MCC philanthropy meeting hosted by the

Dr Peter Merkel Shares Highlights - Detailed Overview & Context

Paul Nghiem talks about the future of MCC treatment and how far we have come in 10+ years. He emphasizes how patients are ... Dr. Peter A. Merkel of UPenn on VCRC and Relapsing Polychondritis (RP) Recording of the June 13, 2025, virtual MCC philanthropy meeting hosted by the Dr. Hamid on the FDA Approval of Pembrolizumab in Merkel Cell Carcinoma In our latest episode of Here We Stand, renowned physicians Paul Nghiem talks about navigating the initial diagnosis of

Earn CME for related activities: In this Velocity Vlog™ activity, Presented July 17, 2024 by the AHNS Cutaneous Cancer Section. Paul Nghiem, MD, PhD, Michael Piepkorn Endowed Chair in Dermatology Research, professor of Dermatology/Medicine at Fred ... The event will include MCC support groups, lab tours, poster session, and a presentation

Photo Gallery

Dr. Peter Merkel shares highlights from his session @ AWIR 2024
The ADVOCATE Trial: A Conversation with Dr. Peter A. Merkel
Navigating Merkel Cell Carcinoma with Dr. Paul Nghiem: Part 5 Future Directions
Dr. Peter Merkel, Dr. Nora Sandorfi, Dr. Steven Kawut 052116 Schleroderma
Surgical Management of Merkel Cell Carcinoma
Dr. Peter A. Merkel of UPenn on VCRC and Relapsing Polychondritis (RP)
Empowering Progress in Merkel Cell Carcinoma: A Conversation with Dr. Paul Nghiem
Dr. Hamid on the FDA Approval of Pembrolizumab in Merkel Cell Carcinoma
7-year old Merkel boy battles rare form of Leukemia
100-Year-Old Secret to Prevent Hantavirus and Ebola? - Dr. Seheult, Dr Nedley
Navigating Merkel Cell Carcinoma with Dr. Paul Nghiem: Part 1 Initial Treatment
2025 Merkel CELLebration
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored